Thomas Trimarchi, President and CFO at BridgeBio Pharma, Inc. (BBIO), sold 45,819 shares at $74.71 ($3.4M) on 2026-02-17, disclosed to the SEC on 2026-02-18.
Open-market sale of $3.4M BBIO by President and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.25 | 18,819 | $1.4M | 41.2% |
| 2 | $74.71 | 13,400 | $1.0M | 29.2% |
| 3 | $74.71 | 13,400 | $1.0M | 29.2% |
| 4 | $75.38 | 200 | $15K | 0.4% |
| Total | $74.93 avg | 45,819 | $3.4M | 100% |
| Filing → |
| BBIO | SELL | 2025-08-22 | $4.2M | — | Filing → |
| BBIO | SELL | 2025-08-19 | $1.7M | — | Filing → |